A number of other equities analysts have also commented on the stock. National Bank Financial decreased their price objective on shares of KP Tissue from C$17.00 to C$15.50 and set a sector perform rating for the company in a research note on Thursday, November 9th. TD Securities decreased their price objective on shares of KP Tissue from C$17.00 to C$15.50 in a research note on Friday. Royal Bank of Canada decreased their price objective on shares of KP Tissue from C$16.00 to C$14.00 and set an outperform rating for the company in a research note on Friday. Desjardins decreased their price objective on shares of KP Tissue from C$17.50 to C$15.00 in a research note on Friday. Finally, CIBC decreased their target price on shares of KP Tissue from C$16.00 to C$14.00 in a research note on Friday.
KP Tissue (KPT) opened at C$11.99 on Friday. KP Tissue has a 52 week low of C$11.77 and a 52 week high of C$16.34. The company has a market cap of $112.86, a P/E ratio of -66.89 and a beta of 0.63.
ILLEGAL ACTIVITY NOTICE: “KP Tissue (KPT) Price Target Lowered to C$15.00 at Scotiabank” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2018/03/13/kp-tissue-kpt-price-target-lowered-to-c15-00-at-scotiabank.html.
KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.